NASDAQ:CDLX Cardlytics (CDLX) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free CDLX Stock Alerts $14.49 -0.15 (-1.02%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$13.80▼$15.7950-Day Range$5.77▼$20.2552-Week Range$2.60▼$20.52Volume3.44 million shsAverage Volume1.68 million shsMarket Capitalization$639.15 millionP/E RatioN/ADividend YieldN/APrice Target$13.20 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Cardlytics alerts: Email Address Cardlytics MarketRank™ Stock AnalysisAnalyst RatingHold2.40 Rating ScoreUpside/Downside8.9% Downside$13.20 Price TargetShort InterestBearish10.16% of Shares Sold ShortDividend StrengthN/ASustainability-0.67Upright™ Environmental ScoreNews Sentiment0.48Based on 13 Articles This WeekInsider TradingAcquiring Shares$8.96 M Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.02 out of 5 starsBusiness Services Sector201st out of 310 stocksComputer Programming, Data Processing, & Other Computer Related Industry35th out of 55 stocks 1.2 Analyst's Opinion Consensus RatingCardlytics has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 3 buy ratings, 1 hold rating, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $13.20, Cardlytics has a forecasted downside of 8.9% from its current price of $14.49.Amount of Analyst CoverageCardlytics has only been the subject of 3 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted10.16% of the outstanding shares of Cardlytics have been sold short.Short Interest Ratio / Days to CoverCardlytics has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cardlytics has recently increased by 2.75%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldCardlytics does not currently pay a dividend.Dividend GrowthCardlytics does not have a long track record of dividend growth. Previous Next 2.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreCardlytics has received a 21.51% net impact score from Upright. Cardlytics seems to create the most significant positive value in categories "Taxes", "Distributing knowledge", and "Jobs". The positive contribution in the "Distributing knowledge" impact category is mostly driven by its "Market intelligence data provision", "Marketing and consumer information services", and "Marketing optimization software" products. See details.Environmental SustainabilityThe Environmental Impact score for Cardlytics is -0.67. Previous Next 3.0 News and Social Media Coverage News SentimentCardlytics has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 13 news articles for Cardlytics this week, compared to 2 articles on an average week.Search Interest40 people have searched for CDLX on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat Follows18 people have added Cardlytics to their MarketBeat watchlist in the last 30 days. This is an increase of 260% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cardlytics insiders have bought 867.48% more of their company's stock than they have sold. Specifically, they have bought $8,963,613.00 in company stock and sold $926,492.00 in company stock.Percentage Held by InsidersOnly 0.78% of the stock of Cardlytics is held by insiders.Percentage Held by Institutions68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Cardlytics is -4.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cardlytics is -4.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCardlytics has a P/B Ratio of 4.22. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About Cardlytics Stock (NASDAQ:CDLX)Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.Read More CDLX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CDLX Stock News HeadlinesMarch 19, 2024 | insidertrades.comInsider Buying: Cardlytics, Inc. (NASDAQ:CDLX) Major Shareholder Buys 311,715 Shares of StockMarch 27, 2024 | msn.comWhy Cardlytics (CDLX) Stock Is Down 30%March 29, 2024 | MarketBeat (Ad)Your $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionMarch 27, 2024 | msn.comIs Cardlytics Stock a Buy After Insider's $13.9M Investment?March 26, 2024 | globenewswire.comCardlytics Prices $150.0 Million Convertible Senior Notes OfferingMarch 26, 2024 | fool.comWhy Cardlytics Stock Tanked by 33% TodayMarch 26, 2024 | msn.comCardlytics stock dips on proposed $150M convertible notes offeringMarch 26, 2024 | globenewswire.comCardlytics Announces Proposed Convertible Senior Notes OfferingMarch 29, 2024 | Crypto Swap Profits (Ad)Did You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.March 24, 2024 | msn.comStellantis, Other Beneficial Owners Love These 7 StocksMarch 24, 2024 | americanbankingnews.comCardlytics (NASDAQ:CDLX) Shares Gap Up to $15.24March 21, 2024 | finance.yahoo.comCDLX May 2024 12.500 callMarch 20, 2024 | finance.yahoo.comCDLX Jul 2024 17.500 putMarch 20, 2024 | americanbankingnews.comCardlytics (NASDAQ:CDLX) Shares Up 4.3% Following Insider Buying ActivityMarch 19, 2024 | americanbankingnews.comCardlytics, Inc. (NASDAQ:CDLX) Major Shareholder Clifford Sosin Buys 311,715 Shares of StockMarch 19, 2024 | americanbankingnews.comCardlytics, Inc. (NASDAQ:CDLX) Major Shareholder Clifford Sosin Acquires 350,000 SharesMarch 19, 2024 | americanbankingnews.comNeedham & Company LLC Increases Cardlytics (NASDAQ:CDLX) Price Target to $15.00March 19, 2024 | americanbankingnews.comLake Street Capital Raises Cardlytics (NASDAQ:CDLX) Price Target to $18.00March 19, 2024 | americanbankingnews.comNeedham & Company LLC Raises Cardlytics (NASDAQ:CDLX) Price Target to $15.00March 19, 2024 | americanbankingnews.comLake Street Capital Boosts Cardlytics (NASDAQ:CDLX) Price Target to $18.00March 18, 2024 | wsj.comCardlytics Inc.March 16, 2024 | seekingalpha.comCardlytics, Inc. (CDLX) Q4 2023 Earnings Call TranscriptMarch 16, 2024 | finance.yahoo.comCardlytics Full Year 2023 Earnings: EPS Misses ExpectationsMarch 16, 2024 | finance.yahoo.comIs Now The Time To Look At Buying Cardlytics, Inc. (NASDAQ:CDLX)?March 16, 2024 | msn.comWhy Cardlytics Stock Is Racing Higher After EarningsMarch 15, 2024 | fool.comHere's Why Cardlytics Stock Absolutely Skyrocketed TodayMarch 15, 2024 | markets.businessinsider.comBlend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On FridaySee More Headlines Receive CDLX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/04/2021Today3/29/2024Next Earnings (Estimated)5/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Computer programming, data processing, & other computer related Sub-IndustryN/A Current SymbolNASDAQ:CDLX CUSIPN/A CIK1666071 Webwww.cardlytics.com Phone(888) 798-5802FaxN/AEmployees473Year Founded2008Price Target and Rating Average Stock Price Target$13.20 High Stock Price Target$18.00 Low Stock Price Target$6.00 Potential Upside/Downside-8.9%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($3.46) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-134,700,000.00 Net Margins-43.56% Pretax Margin-43.56% Return on Equity-25.38% Return on Assets-8.32% Debt Debt-to-Equity Ratio1.91 Current Ratio1.31 Quick Ratio1.31 Sales & Book Value Annual Sales$309.20 million Price / Sales2.07 Cash Flow$1.34 per share Price / Cash Flow10.84 Book Value$3.43 per share Price / Book4.22Miscellaneous Outstanding Shares44,110,000Free Float43,765,000Market Cap$639.15 million OptionableOptionable Beta1.36 Social Links 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Karim Temsamani (Age 50)CEO & Director Comp: $424.02kMr. Nick LyntonChief Legal & Privacy Officer and SecretaryMs. Alexis DeSienoChief Financial OfficerMr. Amit GuptaCOO & GM of BridgMr. Peter ChanChief Technology OfficerMr. Peter DaviesHead of Sales Strategy & OperationsMs. Carson NappsHead of PeopleMr. Jose SingerChief Product OfficerMs. Evelyne ForesterChief Business OfficerMore ExecutivesKey CompetitorsEventbriteNYSE:EBViant TechnologyNASDAQ:DSPDada NexusNASDAQ:DADAVimeoNASDAQ:VMEOHealth CatalystNASDAQ:HCATView All CompetitorsInsiders & InstitutionsNomura Holdings Inc.Bought 72,400 shares on 3/27/2024Ownership: 0.000%Clifford SosinBought 350,000 shares on 3/18/2024Total: $4.69 M ($13.40/share)Clifford SosinBought 311,715 shares on 3/15/2024Total: $4.27 M ($13.71/share)Vanguard Group Inc.Bought 142,085 shares on 3/11/2024Ownership: 5.487%Goldman Sachs Group Inc.Bought 40,911 shares on 3/1/2024Ownership: 0.756%View All Insider TransactionsView All Institutional Transactions CDLX Stock Analysis - Frequently Asked Questions Should I buy or sell Cardlytics stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last twelve months. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CDLX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDLX, but not buy additional shares or sell existing shares. View CDLX analyst ratings or view top-rated stocks. What is Cardlytics' stock price target for 2024? 5 Wall Street analysts have issued 12-month price targets for Cardlytics' shares. Their CDLX share price targets range from $6.00 to $18.00. On average, they predict the company's stock price to reach $13.20 in the next twelve months. This suggests that the stock has a possible downside of 8.9%. View analysts price targets for CDLX or view top-rated stocks among Wall Street analysts. How have CDLX shares performed in 2024? Cardlytics' stock was trading at $9.21 at the beginning of 2024. Since then, CDLX stock has increased by 57.3% and is now trading at $14.49. View the best growth stocks for 2024 here. When is Cardlytics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our CDLX earnings forecast. How were Cardlytics' earnings last quarter? Cardlytics, Inc. (NASDAQ:CDLX) released its quarterly earnings results on Tuesday, May, 4th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.56) by $0.22. The business earned $53 million during the quarter, compared to analyst estimates of $51.96 million. Cardlytics had a negative net margin of 43.56% and a negative trailing twelve-month return on equity of 25.38%. Cardlytics's revenue for the quarter was up 16.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.26) earnings per share. Read the conference call transcript. What guidance has Cardlytics issued on next quarter's earnings? Cardlytics updated its first quarter 2024 earnings guidance on Thursday, March, 14th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $70.0 million-$73.0 million, compared to the consensus revenue estimate of $66.5 million. What is Lynne Laube's approval rating as Cardlytics' CEO? 26 employees have rated Cardlytics Chief Executive Officer Lynne Laube on Glassdoor.com. Lynne Laube has an approval rating of 86% among the company's employees. 61.0% of employees surveyed would recommend working at Cardlytics to a friend. What other stocks do shareholders of Cardlytics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include NVIDIA (NVDA), Block (SQ), DocuSign (DOCU), Advanced Micro Devices (AMD), Caterpillar (CAT), Walt Disney (DIS), Alibaba Group (BABA), Trade Desk (TTD), QUALCOMM (QCOM) and Twilio (TWLO). When did Cardlytics IPO? Cardlytics (CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan served as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers. Who are Cardlytics' major shareholders? Cardlytics' stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (5.49%), Vanguard Group Inc. (5.49%), Worldly Partners Management LLC (2.95%), Baillie Gifford & Co. (2.41%), Dimensional Fund Advisors LP (1.90%) and General Equity Holdings LP (1.59%). Insiders that own company stock include Amit Gupta, Andrew Christiansen, Clifford Sosin, John V Balen, John V Balen, Karim Saad Temsamani, Kirk Somers, Lynne Marie Laube, Nicholas Hollmeyer Lynton, S Aimee Lapic, Scott D Grimes and Scott D Grimes. View institutional ownership trends. How do I buy shares of Cardlytics? Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does Cardlytics have any subsidiaries? The following companies are subsidiares of Cardlytics: Bridg, Cardlytics Services India Private Limited, Cardlytics UK Limited, and DOSH.Read More This page (NASDAQ:CDLX) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardlytics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.